{"disease":{"id":"compensated-cirrhosis","name":"Compensated cirrhosis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"seladelpar","indication_name":"decompensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Livdelzi","generic_name":"SELADELPAR","company_name":"Gilead Sciences Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":64,"revenue":"200","mechanism":"Livdelzi works by inhibiting the activity of a specific enzyme involved in the progression of liver disease."},{"drug_id":"sovaldi","indication_name":"Compensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sovaldi","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Cereblon isoform 4, Genome polyprotein, NS5","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"sovaldi","indication_name":"Decompensated cirrhosis of liver","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sovaldi","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Cereblon isoform 4, Genome polyprotein, NS5","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"elafibranor","indication_name":"Decompensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iqirvo","generic_name":"ELAFIBRANOR","company_name":"Ipsen","drug_phase":"marketed","molecular_target":"","drug_class":"Peroxisome Proliferator-activated Receptor Agonist [EPC]","quality_score":60,"revenue":null,"mechanism":"Iqirvo works by activating peroxisome proliferator-activated receptors to improve liver function."},{"drug_id":"glecaprevir","indication_name":"Compensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mavyret","generic_name":"GLECAPREVIR","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"","drug_class":"Hepatitis C Virus NS5A Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Mavyret works by blocking the NS3/4A protease enzyme, preventing the hepatitis C virus from replicating."},{"drug_id":"ribavarin","indication_name":"Compensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ribavarin","company_name":"Charles University, Czech Republic","drug_phase":"discontinued","molecular_target":"Cytosolic purine 5'-nucleotidase, Adenosine kinase, Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06977685","title":"Effect of Non-Selective Beta-Blockers on Outcomes in Cirrhosis Patients After Hospitalization: A Retrospective Cohort Using Target Trial Design","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7725,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT04160897","title":"Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Qing XIe","has_results":false},{"nct_id":"NCT03342170","title":"Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis?","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT03540771","title":"Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1494,"lead_sponsor_name":"Albert Einstein Healthcare Network","has_results":true},{"nct_id":"NCT03990753","title":"Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03439254","title":"Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":919,"lead_sponsor_name":"Intercept Pharmaceuticals","has_results":true},{"nct_id":"NCT07087041","title":"A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":735,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06374511","title":"Prospective Cohort Study of Complications and Outcomes in Cirrhosis","phase":"","overall_status":"RECRUITING","enrollment_count":660,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05086536","title":"Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05719051","title":"Albumin Infusion in Inpatients With Decompensated Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":564,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04422223","title":"Prospective Cohort Study of Disease and Outcomes in Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT03820271","title":"New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation","phase":"NA","overall_status":"COMPLETED","enrollment_count":501,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07017426","title":"Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":432,"lead_sponsor_name":"Zhiyun Yang","has_results":false},{"nct_id":"NCT03451292","title":"Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":410,"lead_sponsor_name":"Grifols Therapeutics LLC","has_results":true},{"nct_id":"NCT01939197","title":"A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03529136","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":252,"lead_sponsor_name":"Shandong Qilu Stem Cells Engineering Co., Ltd.","has_results":false},{"nct_id":"NCT05121870","title":"Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Beijing 302 Hospital","has_results":false},{"nct_id":"NCT06147518","title":"To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07082751","title":"Prognostic Model for MASLD Related Cirrhosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT03778775","title":"Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03945487","title":"Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Beijing 302 Hospital","has_results":false},{"nct_id":"NCT03462576","title":"Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17","phase":"","overall_status":"TERMINATED","enrollment_count":199,"lead_sponsor_name":"Meridian Bioscience, Inc.","has_results":true},{"nct_id":"NCT06773221","title":"The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":195,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06855056","title":"Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis","phase":"","overall_status":"RECRUITING","enrollment_count":189,"lead_sponsor_name":"European Foundation for Study of Chronic Liver Failure","has_results":false},{"nct_id":"NCT04210245","title":"Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"NGM Biopharmaceuticals, Inc","has_results":true},{"nct_id":"NCT02738138","title":"A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04906083","title":"Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05863364","title":"Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Xin Zeng","has_results":false},{"nct_id":"NCT02642432","title":"A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05224960","title":"Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Beijing 302 Hospital","has_results":false},{"nct_id":"NCT04208776","title":"Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics With Severe Ascites.","phase":"NA","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07439770","title":"Using Telemedicine to Assist in the Clinical Care of Patients With Decompensated Cirrhosis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05937048","title":"Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT03749954","title":"Detachable String Magnetically Controlled Capsule Endoscopy for Detecting High-risk Varices in Compensated Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":105,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06245590","title":"Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT06212635","title":"Hemostasis in Liver Cirrhosis and Hepatocellular Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT03037151","title":"Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The HIV Netherlands Australia Thailand Research Collaboration","has_results":false},{"nct_id":"NCT04679571","title":"Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT05734001","title":"Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT03547895","title":"Management of Decompensated HCV Cirrhotic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT02467322","title":"To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07413549","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06937307","title":"Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Giuseppe Cullaro, MD","has_results":false},{"nct_id":"NCT05485714","title":"Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"United Arab Emirates University","has_results":false},{"nct_id":"NCT03911037","title":"GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT02207088","title":"Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07002827","title":"Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT05956197","title":"Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":55,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT06344611","title":"Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VII Criteria","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07299110","title":"Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol Related Cirrhosis.","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}